Matches in SemOpenAlex for { <https://semopenalex.org/work/W115392064> ?p ?o ?g. }
- W115392064 endingPage "313" @default.
- W115392064 startingPage "301" @default.
- W115392064 abstract "At present pharmacotherapy of Alzheimer's disease (AD) is limited to acetylcholinesterase inhibitors. These drugs produce small, but consistent improvements of memory and global function, some are also positively influencing activities of daily living. This therapeutic approach neglects the complexity of AD and the fact that most of the degenerating neurons are not cholinergic. Acetylcholinesterase inhibitors are symptomatic drugs, with no influence on disease progression. There is a need for disease modifying compounds, or preventive drugs. Data are indicating that vitamin E has some ability to influence the disease progression. The potency of non-steroidal anti-inflammatory drugs (NSAIDs) or estrogen as preventive agents has to be explored further in prospective clinical studies. The initial hope in the use of naturally occurring neurotrophic factors, like nerve growth factor, to rescue cholinergic neurons from degeneration and to restore cognitive function has been disappointed in first, small clinical studies. The peptidergic drug Cerebrolysin exhibiting neurotrophic stimulation, neuroimmunotrophic regulation and induction of BBB glucose transporter expression, might be able to address the pathological changes of AD at different levels simultaneously. In addition to an impressive preclinical database, results from 3 placebo-controlled, double-blind studies demonstrate significant improvements of cognitive performance, global function and activities of daily living in AD patients. In all studies persisting improvements, up to 6 months after drug withdrawal, indicate a powerful disease modifying activity." @default.
- W115392064 created "2016-06-24" @default.
- W115392064 creator A5065203513 @default.
- W115392064 date "2000-01-01" @default.
- W115392064 modified "2023-10-02" @default.
- W115392064 title "Approach towards an integrative drug treatment of Alzheimer’s disease" @default.
- W115392064 cites W1487246579 @default.
- W115392064 cites W1886946231 @default.
- W115392064 cites W1963783263 @default.
- W115392064 cites W1965670935 @default.
- W115392064 cites W1967664485 @default.
- W115392064 cites W1969885981 @default.
- W115392064 cites W1972300483 @default.
- W115392064 cites W1977189529 @default.
- W115392064 cites W1977374270 @default.
- W115392064 cites W1980156193 @default.
- W115392064 cites W1988651884 @default.
- W115392064 cites W1989525162 @default.
- W115392064 cites W1990543766 @default.
- W115392064 cites W1993820899 @default.
- W115392064 cites W1994083407 @default.
- W115392064 cites W1999886806 @default.
- W115392064 cites W2002496882 @default.
- W115392064 cites W2008350281 @default.
- W115392064 cites W2009646399 @default.
- W115392064 cites W2016958718 @default.
- W115392064 cites W2019519108 @default.
- W115392064 cites W2025611371 @default.
- W115392064 cites W2027367487 @default.
- W115392064 cites W2028980047 @default.
- W115392064 cites W2032490010 @default.
- W115392064 cites W2032712904 @default.
- W115392064 cites W2036898214 @default.
- W115392064 cites W2042545331 @default.
- W115392064 cites W2042920190 @default.
- W115392064 cites W2044061635 @default.
- W115392064 cites W2048832465 @default.
- W115392064 cites W2050257377 @default.
- W115392064 cites W2055453667 @default.
- W115392064 cites W2055746351 @default.
- W115392064 cites W2055949908 @default.
- W115392064 cites W2057013121 @default.
- W115392064 cites W2057099669 @default.
- W115392064 cites W2057679568 @default.
- W115392064 cites W2066077729 @default.
- W115392064 cites W2067581131 @default.
- W115392064 cites W2068130550 @default.
- W115392064 cites W2069700086 @default.
- W115392064 cites W2072525898 @default.
- W115392064 cites W2073909805 @default.
- W115392064 cites W2081522004 @default.
- W115392064 cites W2082736694 @default.
- W115392064 cites W2083796509 @default.
- W115392064 cites W2084275633 @default.
- W115392064 cites W2087655177 @default.
- W115392064 cites W2087883935 @default.
- W115392064 cites W2089194292 @default.
- W115392064 cites W2097287453 @default.
- W115392064 cites W2109366922 @default.
- W115392064 cites W2118013379 @default.
- W115392064 cites W2133019124 @default.
- W115392064 cites W2137777161 @default.
- W115392064 cites W2138034817 @default.
- W115392064 cites W2140284221 @default.
- W115392064 cites W2147514358 @default.
- W115392064 cites W2147574361 @default.
- W115392064 cites W2156021708 @default.
- W115392064 cites W2163110760 @default.
- W115392064 cites W2326200998 @default.
- W115392064 cites W244508287 @default.
- W115392064 cites W324218948 @default.
- W115392064 cites W5697170 @default.
- W115392064 cites W59536211 @default.
- W115392064 cites W656755 @default.
- W115392064 cites W249327392 @default.
- W115392064 doi "https://doi.org/10.1007/978-3-7091-6781-6_32" @default.
- W115392064 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10961442" @default.
- W115392064 hasPublicationYear "2000" @default.
- W115392064 type Work @default.
- W115392064 sameAs 115392064 @default.
- W115392064 citedByCount "6" @default.
- W115392064 countsByYear W1153920642017 @default.
- W115392064 countsByYear W1153920642023 @default.
- W115392064 crossrefType "book-chapter" @default.
- W115392064 hasAuthorship W115392064A5065203513 @default.
- W115392064 hasConcept C103637391 @default.
- W115392064 hasConcept C104966671 @default.
- W115392064 hasConcept C126322002 @default.
- W115392064 hasConcept C15744967 @default.
- W115392064 hasConcept C160539049 @default.
- W115392064 hasConcept C16568411 @default.
- W115392064 hasConcept C169760540 @default.
- W115392064 hasConcept C170493617 @default.
- W115392064 hasConcept C181199279 @default.
- W115392064 hasConcept C22885893 @default.
- W115392064 hasConcept C25498285 @default.
- W115392064 hasConcept C2776149669 @default.
- W115392064 hasConcept C2778816929 @default.